Boston Type 1 Keratoprosthesis: Updated Perspectives

References

• Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221–e34. doi:10.1016/S2214-109X(17)30393-5
   PubMed Web of Science ®Google Scholar
• Mathews PM, Lindsley K, Aldave AJ, Akpek EK. Etiology of global corneal blindness and current practices of corneal transplantation: a focused review. Cornea. 2018;37(9):1198–1203. doi:10.1097/ICO.0000000000001666
   PubMed Web of Science ®Google Scholar
• Matthaei M, Sandhaeger H, Hermel M, et al. Changing indications in penetrating keratoplasty: a systematic review of 34 years of global reporting. Transplantation. 2017;101(6):1387–1399. doi:10.1097/TP.0000000000001281
   PubMed Web of Science ®Google Scholar
• Chodosh J FDA approval obtained for the Boston Keratoprosthesis type I Lucia design. BOSTON KPro news; July 2019.
   Google Scholar
• Ilhan-Sarac O, Akpek EK. Current concepts and techniques in keratoprosthesis. Curr Opin Ophthalmol. 2005;16(4):246–250. doi:10.1097/01.icu.0000172829.33770.d3
   Google Scholar
• Traish AS, Chodosh J. Expanding application of the Boston type I keratoprosthesis due to advances in design and improved post-operative therapeutic strategies. Semin Ophthalmol. 2010;25(5–6):239–243. doi:10.3109/08820538.2010.518895
   PubMed Web of Science ®Google Scholar
• Dohlman CH, Harissi-Dagher M, Graney J. The Boston Keratoprosthesis: a new threadless design. Digit J Ophthalmol. 2007;13(3).
   Google Scholar
• Harissi-Dagher M, Khan BF, Schaumberg DA, Dohlman CH. Importance of nutrition to corneal grafts when used as a carrier of the Boston Keratoprosthesis. Cornea. 2007;26(5):564–568. doi:10.1097/ICO.0b013e318041f0a6
   PubMed Web of Science ®Google Scholar
• Tan XW, Riau A, Shi ZL, et al. In vitro effect of a corrosive hostile ocular surface on candidate biomaterials for keratoprosthesis skirt. Br J Ophthalmol. 2012;96(9):1252–1258. doi:10.1136/bjophthalmol-2012-301633
   PubMed Web of Science ®Google Scholar
• Dong Y, Yang J, Wang L, et al. An improved biofunction of titanium for keratoprosthesis by hydroxyapatite-coating. J Biomater Appl. 2014;28(7):990–997. doi:10.1177/0885328213490312
   Web of Science ®Google Scholar
• Paschalis EI, Chodosh J, Spurr-Michaud S, et al. In vitro and in vivo assessment of titanium surface modification for coloring the backplate of the Boston keratoprosthesis. Invest Ophthalmol Vis Sci. 2013;54(6):3863–3873. doi:10.1167/iovs.13-11714
   PubMed Web of Science ®Google Scholar
• Todani A, Ciolino JB, Ament JD, et al. Titanium back plate for a PMMA keratoprosthesis: clinical outcomes. Graefes Arch Clin Exp Ophthalmol. 2011;249(10):1515–1518. doi:10.1007/s00417-011-1684-y
   PubMed Web of Science ®Google Scholar
• Talati RK, Hallak JA, Karas FI, de la Cruz J, Cortina MS. Retroprosthetic membrane formation in Boston Keratoprosthesis: a case-control-matched comparison of titanium versus PMMA backplate. Cornea. 2018;37(2):145–150. doi:10.1097/ICO.0000000000001462
   Web of Science ®Google Scholar
• Taniguchi EV, Paschalis EI, Crnej A, et al. The role of the back plate in angle anatomy with the Boston type I keratoprosthesis. Cornea. 2017;36(9):1096–1101. doi:10.1097/ICO.0000000000001248
   Web of Science ®Google Scholar
• Basu S, Serna-Ojeda JC, Senthil S, Pappuru RR, Bagga B, Sangwan V. The aurolab keratoprosthesis (KPro) versus the Boston type I Kpro: 5-year clinical outcomes in 134 cases of bilateral corneal blindness. Am J Ophthalmol. 2019;205:175–183. doi:10.1016/j.ajo.2019.03.016
   Web of Science ®Google Scholar
• Bakshi SK, Paschalis EI, Graney J, Lucia CJ. Beyond: development of an affordable keratoprosthesis. Cornea. 2019;38(4):492–497. doi:10.1097/ICO.0000000000001880
   PubMed Web of Science ®Google Scholar
• Ahmad S, Akpek EK, Gehlbach PL, Dunlap K, Ramulu PY. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation. Am J Ophthalmol. 2015;159(4):739–747. doi:10.1016/j.ajo.2014.12.024
   PubMed Web of Science ®Google Scholar
• Driver TH, Aravena C, Duong HNV, et al. Outcomes of the Boston type I keratoprosthesis as the primary penetrating corneal procedure. Cornea. 2018;37(11):1400–1407. doi:10.1097/ICO.0000000000001735
   PubMed Web of Science ®Google Scholar
• Aravena C, Yu F, Aldave AJ. Long-term visual outcomes, complications, and retention of the Boston type I keratoprosthesis. Cornea. 2018;37(1):3–10. doi:10.1097/ICO.0000000000001405
   Web of Science ®Google Scholar
• Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology. 2011;118(8):1543–1550. doi:10.1016/j.ophtha.2010.12.032
   PubMed Web of Science ®Google Scholar
• Lekhanont K, Thaweesit P, Muntham D, Chuckpaiwong V, Vongthongsri A. Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand. Cornea. 2014;33(12):1312–1319. doi:10.1097/ICO.0000000000000265
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang C, Liu Q, Wang Z, Gao M. Comparison of the clinical efficacy of Boston keratoprosthesis type I and repetitive penetrating keratoplasty for refractory keratopathy. J Craniofac Surg. 2020;31(2):e194–e199. doi:10.1097/SCS.0000000000006164
   Web of Science ®Google Scholar
• Ahmad S, Mathews PM, Lindsley K, et al. Boston type 1 keratoprosthesis versus repeat donor keratoplasty for corneal graft failure: a systematic review and meta-analysis. Ophthalmology. 2016;123(1):165–177. doi:10.1016/j.ophtha.2015.09.028
   PubMed Web of Science ®Google Scholar
• Fadous R, Levallois-Gignac S, Vaillancourt L, Robert MC, Harissi-Dagher M. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure. Br J Ophthalmol. 2015;99(12):1664–1668. doi:10.1136/bjophthalmol-2014-306161
   PubMed Web of Science ®Google Scholar
• Kang KB, Karas FI, Rai R, et al. Five year outcomes of Boston type I keratoprosthesis as primary versus secondary penetrating corneal procedure in a matched case control study. PLoS One. 2018;13(2):e0192381. doi:10.1371/journal.pone.0192381
   PubMed Web of Science ®Google Scholar
• Huang C, O’Hara M, Mannis MJ. Primary pediatric keratoplasty: indications and outcomes. Cornea. 2009;28(9):1003–1008. doi:10.1097/ICO.0b013e3181a186c0
   PubMed Web of Science ®Google Scholar
• Fung SSM, Jabbour S, Harissi-Dagher M, et al. Visual outcomes and complications of type I Boston keratoprosthesis in children: a retrospective multicenter study and literature review. Ophthalmology. 2018;125(2):153–160. doi:10.1016/j.ophtha.2017.07.009
   Web of Science ®Google Scholar
• Kosker M, Suri K, Rapuano CJ, et al. Long-term results of the Boston keratoprosthesis for unilateral corneal disease. Cornea. 2015;34(9):1057–1062. doi:10.1097/ICO.0000000000000495
   Web of Science ®Google Scholar
• Cortina MS, Hallak JA. Vision-related quality-of-life assessment using NEI VFQ-25 in patients after Boston keratoprosthesis implantation. Cornea. 2015;34(2):160–164. doi:10.1097/ICO.0000000000000310
   Web of Science ®Google Scholar
• Pineles SL, Ela-Dalman N, Rosenbaum AL, Aldave AJ, Velez FG. Binocular visual function in patients with Boston type I keratoprostheses. Cornea. 2010;29(12):1397–1400. doi:10.1097/ICO.0b013e3181da58d0
   Web of Science ®Google Scholar
• Shanbhag SS, Saeed HN, Colby KA, Chodosh J. Comparative outcomes of Boston keratoprosthesis type 1 implantation based on vision in the contralateral eye. Cornea. 2018;37(11):1408–1413. doi:10.1097/ICO.0000000000001721
   Web of Science ®Google Scholar
• Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116(4):640–651. doi:10.1016/j.ophtha.2008.12.058
   PubMed Web of Science ®Google Scholar
• Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: the university of california davis experience. Cornea. 2009;28(3):321–327. doi:10.1097/ICO.0b013e31818b8bfa
   PubMed Web of Science ®Google Scholar
• Ciolino JB, Belin MW, Todani A, Al-Arfaj K, Rudnisky CJ. Boston keratoprosthesis type 1 study G. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology. 2013;120(6):1195–1200. doi:10.1016/j.ophtha.2012.11.025
   PubMed Web of Science ®Google Scholar
• Chang HY, Luo ZK, Chodosh J, Dohlman CH, Colby KA. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases. Cornea. 2015;34(3):264–270. doi:10.1097/ICO.0000000000000357
   Web of Science ®Google Scholar
• Samarawickrama C, Strouthidis N, Wilkins MR. Boston keratoprosthesis type 1: outcomes of the first 38 cases performed at Moorfields Eye Hospital. Eye (Lond). 2018;32(6):1087–1092. doi:10.1038/s41433-018-0016-4
   Web of Science ®Google Scholar
• Srikumaran D, Munoz B, Aldave AJ, et al. Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort. Ophthalmology. 2014;121(11):2159–2164. doi:10.1016/j.ophtha.2014.05.030
   PubMed Web of Science ®Google Scholar
• Homayounfar G, Grassi CM, Al-Moujahed A, Colby KA, Dohlman CH, Chodosh J. Boston keratoprosthesis type I in the elderly. Br J Ophthalmol. 2017;101(4):514–518. doi:10.1136/bjophthalmol-2015-307868
   Web of Science ®Google Scholar
• Aravena C, Bozkurt TK, Yu F, Aldave AJ. Long-term outcomes of the Boston type I keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea. 2016;35(9):1156–1164. doi:10.1097/ICO.0000000000000933
   PubMed Web of Science ®Google Scholar
• Goins KM, Kitzmann AS, Greiner MA, et al. Boston type 1 keratoprosthesis: visual outcomes, device retention, and complications. Cornea. 2016;35(9):1165–1174. doi:10.1097/ICO.0000000000000886
   PubMed Web of Science ®Google Scholar
• Sayegh RR, Ang LP, Foster CS, Dohlman CH. The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol. 2008;145(3):438–444. doi:10.1016/j.ajo.2007.11.002
   PubMed Web of Science ®Google Scholar
• Palioura S, Kim B, Dohlman CH, Chodosh J. The Boston keratoprosthesis type I in mucous membrane pemphigoid. Cornea. 2013;32(7):956–961. doi:10.1097/ICO.0b013e318286fd73
   Web of Science ®Google Scholar
• Alexander JK, Basak SK, Padilla MD, Yu F, Aldave AJ. International outcomes of the Boston type I keratoprosthesis in Stevens-Johnson syndrome. Cornea. 2015;34(11):1387–1394. doi:10.1097/ICO.0000000000000619
   Web of Science ®Google Scholar
• Shah KJ, Cheung AY, Holland EJ. Intermediate-term and long-term outcomes with the Boston type 1 keratoprosthesis in aniridia. Cornea. 2018;37(1):11–14. doi:10.1097/ICO.0000000000001412
   Web of Science ®Google Scholar
• Salvador-Culla B, Kolovou PE, Arzeno L, Martinez S, Lopez MA. Boston Keratoprosthesis Type 1 in chemical burns. Cornea. 2016;35(6):911–916. doi:10.1097/ICO.0000000000000837
   PubMed Web of Science ®Google Scholar
• Shanbhag SS, Saeed HN, Paschalis EI, Chodosh J. Boston keratoprosthesis type 1 for limbal stem cell deficiency after severe chemical corneal injury: a systematic review. Ocul Surf. 2018;16(3):272–281. doi:10.1016/j.jtos.2018.03.007
   PubMed Web of Science ®Google Scholar
• Brown CR, Wagoner MD, Welder JD, et al. Boston keratoprosthesis type 1 for herpes simplex and herpes zoster keratopathy. Cornea. 2014;33(8):801–805. doi:10.1097/ICO.0000000000000164
   Web of Science ®Google Scholar
• Fry M, Aravena C, Yu F, Kattan J, Aldave AJ. Long-term outcomes of the Boston type I keratoprosthesis in eyes with previous herpes simplex virus keratitis. Br J Ophthalmol. 2018;102(1):48–53. doi:10.1136/bjophthalmol-2017-310186
   Web of Science ®Google Scholar
• Phillips DL, Hager JL, Goins KM, et al. Boston type 1 keratoprosthesis for chemical and thermal injury. Cornea. 2014;33(9):905–909. doi:10.1097/ICO.0000000000000204
   PubMed Web of Science ®Google Scholar
• Hassanaly SI, Talajic JC, Harissi-Dagher M. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal. Am J Ophthalmol. 2014;158(2):270–6 e1. doi:10.1016/j.ajo.2014.05.009
   Web of Science ®Google Scholar
• Priddy J, Bardan AS, Tawfik HS, Liu C. Systematic review and meta-analysis of the medium- and long-term outcomes of the Boston type 1 keratoprosthesis. Cornea. 2019;38:1465–1473. doi:10.1097/ICO.0000000000002098
   Web of Science ®Google Scholar
• Magalhaes FP, Hirai FE, de Sousa LB, de Oliveira LA. Boston type 1 keratoprosthesis outcomes in ocular burns. Acta Ophthalmol. 2013;91(6):e432–e436. doi:10.1111/aos.12083
   Web of Science ®Google Scholar
• Rudnisky CJ, Belin MW, Todani A, et al. Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology. 2012;119(5):951–955. doi:10.1016/j.ophtha.2011.11.030
   PubMed Web of Science ®Google Scholar
• Dokey A, Ramulu PY, Utine CA, et al. Chronic hypotony associated with the Boston type 1 keratoprosthesis. Am J Ophthalmol. 2012;154(2):266–71.e1. doi:10.1016/j.ajo.2012.03.001
   Web of Science ®Google Scholar
• Sivaraman KR, Hou JH, Allemann N, de la Cruz J, Cortina MS. Retroprosthetic membrane and risk of sterile keratolysis in patients with type I Boston Keratoprosthesis. Am J Ophthalmol. 2013;155(5):814–822. doi:10.1016/j.ajo.2012.11.019
   PubMed Web of Science ®Google Scholar
• Sejpal K, Yu F, Aldave AJ. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea. 2011;30(11):1187–1194. doi:10.1097/ICO.0b013e3182114467
   PubMed Web of Science ®Google Scholar
• Harissi-Dagher M, Beyer J, Dohlman CH. The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin. 2008;48(2):43–51. doi:10.1097/IIO.0b013e318169511f
   PubMedGoogle Scholar
• Hicks CR, Crawford GJ. Melting after keratoprosthesis implantation: the effects of medroxyprogesterone. Cornea. 2003;22(6):497–500. doi:10.1097/00003226-200308000-00001
   PubMed Web of Science ®Google Scholar
• Chan CC, LoVerde L, Qiang J, Nordlund ML, Holland EJ. Incidence, risk factors, and surgical management of Boston type 1 keratoprosthesis corneal melts, leaks, and extrusions. Cornea. 2016;35(8):1049–1056. doi:10.1097/ICO.0000000000000911
   Web of Science ®Google Scholar
• Tay E, Utine CA, Akpek EK. Crescenteric amniotic membrane grafting in keratoprosthesis-associated corneal melt. Arch Ophthalmol. 2010;128(6):779–782.
   Google Scholar
• Ziai S, Rootman DS, Slomovic AR, Chan CC. Oral buccal mucous membrane allograft with a corneal lamellar graft for the repair of Boston type 1 keratoprosthesis stromal melts. Cornea. 2013;32(11):1516–1519. doi:10.1097/ICO.0b013e3182a480f5
   PubMed Web of Science ®Google Scholar
• Ali MH, Dikopf MS, Finder AG, et al. Assessment of glaucomatous damage after Boston keratoprosthesis implantation based on digital planimetric quantification of visual fields and optic nerve head imaging. Cornea. 2018;37(5):602–608. doi:10.1097/ICO.0000000000001544
   PubMed Web of Science ®Google Scholar
• Kang JJ, Allemann N, Cruz Jde L, Cortina MS. Serial analysis of anterior chamber depth and angle status using anterior segment optical coherence tomography after boston keratoprosthesis. Cornea. 2013;32(10):1369–1374. doi:10.1097/ICO.0b013e3182a0cff5
   PubMed Web of Science ®Google Scholar
• Qian CX, Hassanaly S, Harissi-Dagher M. Anterior segment optical coherence tomography in the long-term follow-up and detection of glaucoma in Boston type I keratoprosthesis. Ophthalmology. 2015;122(2):317–325. doi:10.1016/j.ophtha.2014.08.007
   PubMed Web of Science ®Google Scholar
• Nguyen P, Chopra V. Glaucoma management in Boston keratoprosthesis type I recipients. Curr Opin Ophthalmol. 2014;25(2):134–140. doi:10.1097/ICU.0000000000000035
   Web of Science ®Google Scholar
• Rivier D, Paula JS, Kim E, Dohlman CH, Grosskreutz CL. Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation. J Glaucoma. 2009;18(4):321–324. doi:10.1097/IJG.0b013e3181815485
   PubMed Web of Science ®Google Scholar
• Vajaranant TS, Liu J, Wilensky J, Cortina MS, Aref AA. Innovative approaches to glaucoma management of Boston keratoprosthesis type 1. Curr Ophthalmol Rep. 2016;4(3):147–153. doi:10.1007/s40135-016-0102-3
   PubMedGoogle Scholar
• Crnej A, Paschalis EI, Salvador-Culla B, et al. Glaucoma progression and role of glaucoma surgery in patients with Boston keratoprosthesis. Cornea. 2014;33(4):349–354. doi:10.1097/ICO.0000000000000067
   PubMed Web of Science ®Google Scholar
• Lenis TL, Chiu SY, Law SK, Yu F, Aldave AJ. Safety of concurrent Boston type I keratoprosthesis and glaucoma drainage device implantation. Ophthalmology. 2017;124(1):12–19. doi:10.1016/j.ophtha.2016.08.003
   PubMed Web of Science ®Google Scholar
• Li JY, Greiner MA, Brandt JD, Lim MC, Mannis MJ. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis. Am J Ophthalmol. 2011;152(2):209–218. doi:10.1016/j.ajo.2011.01.034
   PubMed Web of Science ®Google Scholar
• Huh ES, Aref AA, Vajaranant TS, de la Cruz J, Chau FY, Cortina MS. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery. J Glaucoma. 2014;23(1):e39–e44. doi:10.1097/IJG.0b013e31829e55f8
   PubMed Web of Science ®Google Scholar
• Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001;119(4):484–489. doi:10.1001/archopht.119.4.484
   PubMedGoogle Scholar
• Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol. 2012;96(6):776–780. doi:10.1136/bjophthalmol-2011-301263
   PubMed Web of Science ®Google Scholar
• Behlau I, Martin KV, Martin JN, et al. Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention. Acta Ophthalmol. 2014;92(7):e546–e555. doi:10.1111/aos.12309
   PubMed Web of Science ®Google Scholar
• Barnes SD, Dohlman CH, Durand ML. Fungal colonization and infection in Boston keratoprosthesis. Cornea. 2007;26(1):9–15. doi:10.1097/01.ico.0000224650.19837.25
   PubMed Web of Science ®Google Scholar
• Chan CC, Holland EJ. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation. Cornea. 2012;31(4):346–349. doi:10.1097/ICO.0b013e31821eea2f
   PubMed Web of Science ®Google Scholar
• Foulks GN. Prolonging contact lens wear and making contact lens wear safer. Am J Ophthalmol. 2006;141(2):369–373. doi:10.1016/j.ajo.2005.08.047
   Web of Science ®Google Scholar
• Goldman DR, Hubschman JP, Aldave AJ, et al. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina. 2013;33(3):532–541. doi:10.1097/IAE.0b013e3182641848
   PubMed Web of Science ®Google Scholar
• Rishi P, Rishi E, Koundanya VV, Mathur G, Iyer G, Srinivasan B. Vitreoretinal complications in eyes with boston keratoprosthesis type I. Retina. 2016;36(3):603–610. doi:10.1097/IAE.0000000000000740
   Web of Science ®Google Scholar
• Moshiri A, Safi M, Morse LS, et al. Posterior segment complications and impact on long-term visual outcomes in eyes with a type 1 Boston keratoprosthesis. Cornea. 2019;38(9):1111–1116. doi:10.1097/ICO.0000000000001983
   Web of Science ®Google Scholar
• Ray S, Khan BF, Dohlman CH, D’Amico DJ. Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol. 2002;120(5):559–566. doi:10.1001/archopht.120.5.559
   PubMedGoogle Scholar
• Kiang L, Sippel KC, Starr CE, et al. Vitreoretinal surgery in the setting of permanent keratoprosthesis. Arch Ophthalmol. 2012;130(4):487–492. doi:10.1001/archophthalmol.2011.1115
   PubMedGoogle Scholar
• Estrovich IE, Shen C, Chu Y, et al. Schiotz tonometry accurately measures intraocular pressure in Boston type 1 keratoprosthesis eyes. Cornea. 2015;34(6):682–685. doi:10.1097/ICO.0000000000000406
   PubMed Web of Science ®Google Scholar
• Enders P, Hall J, Bornhauser M, et al. Telemetric intraocular pressure monitoring after Boston keratoprosthesis surgery. Ophthalmology. 2019;126(2):322–324. doi:10.1016/j.ophtha.2018.09.028
   PubMed Web of Science ®Google Scholar
• Hui P-C, Chodosh J, Dohlman CH, Paschalis EI. Integrating a pressure sensor in the Boston KPro. Boston KPro news. July 2019.
   Google Scholar
• Khoueir Z, Jassim F, Braaf B, et al. Three-dimensional optical coherence tomography imaging for glaucoma associated with Boston keratoprosthesis type I and II. J Glaucoma. 2019;28(8):718–726. doi:10.1097/IJG.0000000000001280
   PubMed Web of Science ®Google Scholar
• Carreira AS, Ferreira P, Ribeiro MP, et al. New drug-eluting lenses to be applied as bandages after keratoprosthesis implantation. Int J Pharm. 2014;477(1–2):218–226. doi:10.1016/j.ijpharm.2014.10.037
   Web of Science ®Google Scholar
• Ciolino JB, Stefanescu CF, Ross AE, et al. In vivo performance of a drug-eluting contact lens to treat glaucoma for a month. Biomaterials. 2014;35(1):432–439. doi:10.1016/j.biomaterials.2013.09.032
   PubMed Web of Science ®Google Scholar
• Robert MC, Arafat SN, Ciolino JB. Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients. Eye Contact Lens. 2014;40(6):376–381. doi:10.1097/ICL.0000000000000081
   Web of Science ®Google Scholar
• Paschalis EI, Pineda R, Gonzalez-Andrades M, et al. A New Pre-Descemet’s Keratoprosthesis. Boston KPro news. 2017 September.
   Google Scholar
• Kornberg DL, Yannuzzi NA, Klufas MA, D’Amico DJ, Orlin A, Kiss S. Ultra-widefield imaging of posterior segment pathology in the setting of the Boston keratoprosthesis. Retina. 2016;36(6):1101–1110. doi:10.1097/IAE.0000000000000833
   Web of Science ®Google Scholar
• Muzychuk AK, Robert MC, Dao S, Harissi-Dagher M. Boston keratoprosthesis type 1: a randomized controlled trial of fresh versus frozen corneal donor carriers with long-term follow-up. Ophthalmology. 2017;124(1):20–26. doi:10.1016/j.ophtha.2016.07.019
   PubMed Web of Science ®Google Scholar
• Gonzalez-Andrades M, Sharifi R, Islam MM, et al. Improving the practicality and safety of artificial corneas: pre-assembly and gamma-rays sterilization of the Boston Keratoprosthesis. Ocul Surf. 2018;16(3):322–330. doi:10.1016/j.jtos.2018.04.002
   Web of Science ®Google Scholar
• Islam MM, Sharifi R, Gonzalez-Andrades M. Finding an optimal substitute for human donor corneas. Boston KPro news. July 2019.
   Google Scholar
• Sharifi R, Mahmoudzadeh S, Islam MM, et al. Poly(methyl methacrylate): covalent functionalization of PMMA surface with L-3,4-Dihydroxyphenylalanine (L-DOPA) to enhance its biocompatibility and adhesion to corneal tissue (Adv. Mater. Interfaces 1/2020). Adv Mater Interfaces. 2020;7(1):2070001. doi:10.1002/admi.202070001
   Web of Science ®Google Scholar
• Bakshi SK, Graney J, Paschalis EI, et al. Design and outcomes of a novel keratoprosthesis: addressing unmet needs in end-stage cicatricial corneal blindness. Cornea. Epub 2019 8.
   Web of Science ®Google Scholar